• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3.

作者信息

Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y

出版信息

Int J Cancer. 1995 Dec 11;63(6):883-5. doi: 10.1002/ijc.2910630622.

DOI:10.1002/ijc.2910630622
PMID:8847150
Abstract
摘要

相似文献

1
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3.用由MAGE - 3基因编码的肽治疗的黑色素瘤患者的肿瘤消退反应。
Int J Cancer. 1995 Dec 11;63(6):883-5. doi: 10.1002/ijc.2910630622.
2
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.AS15 免疫佐剂选择用于 MAGE-A3 蛋白的主动免疫：欧洲癌症研究与治疗组织黑色素瘤研究组转移性黑色素瘤随机 II 期研究结果。
J Clin Oncol. 2013 Jul 1;31(19):2413-20. doi: 10.1200/JCO.2012.43.7111. Epub 2013 May 28.
3
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1.在接受由MAGE - 3基因编码并由HLA - A1呈递的抗原肽治疗的转移性黑色素瘤患者中观察到肿瘤消退。
Int J Cancer. 1999 Jan 18;80(2):219-30. doi: 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s.
4
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.重组MAGE-3蛋白皮下及皮内免疫接种用于可检测到转移性黑色素瘤患者的1/2期研究。
Int J Cancer. 2005 Nov 20;117(4):596-604. doi: 10.1002/ijc.21264.
5
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.用MAGE-3肽脉冲处理的成熟树突状细胞对黑色素瘤患者进行疫苗接种可触发非疫苗抗肿瘤细胞的活性。
J Immunol. 2008 Mar 1;180(5):3585-93. doi: 10.4049/jimmunol.180.5.3585.
6
Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein.对接种MAGE-3蛋白疫苗的黑色素瘤患者中抗疫苗CD4 T细胞频率的监测。
J Immunol. 2005 Feb 15;174(4):2404-11. doi: 10.4049/jimmunol.174.4.2404.
7
A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion.一种由MAGE-6编码的肽被浸润自发消退的人类原发性黑色素瘤病变的扩增淋巴细胞识别。
Eur J Immunol. 1999 Feb;29(2):602-7. doi: 10.1002/(SICI)1521-4141(199902)29:02<602::AID-IMMU602>3.0.CO;2-Y.
8
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.人类基因MAGE - 3编码一种抗原，该抗原可被自体溶细胞性T淋巴细胞识别，存在于黑色素瘤中。
J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921.
9
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.黑色素瘤患者接种肿瘤抗原前后血液中抗肿瘤T细胞的高频率。
J Exp Med. 2005 Jan 17;201(2):241-8. doi: 10.1084/jem.20041379.
10
A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.免疫治疗成功后，从黑色素瘤患者中分离出的细胞毒性 T 细胞识别出由免疫蛋白酶体加工的 MAGE-C2 抗原肽。
Int J Cancer. 2011 Nov 15;129(10):2427-34. doi: 10.1002/ijc.25911. Epub 2011 Apr 20.

引用本文的文献

1
Exosome-based cancer vaccine: a cell-free approach.基于外泌体的癌症疫苗：一种无细胞方法。
Mol Biol Rep. 2025 Apr 24;52(1):421. doi: 10.1007/s11033-025-10519-x.
2
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis.鉴定泛癌/睾丸基因，并在三阴性乳腺癌中验证治疗靶点：Lin28a 基和 Siglece 基疫苗诱导抗肿瘤免疫并抑制转移。
J Immunother Cancer. 2023 Dec 22;11(12):e007935. doi: 10.1136/jitc-2023-007935.
3
Methionine oxidation selectively enhances T cell reactivity against a melanoma antigen.
甲硫氨酸氧化选择性增强T细胞对黑色素瘤抗原的反应性。
iScience. 2023 Jun 25;26(7):107205. doi: 10.1016/j.isci.2023.107205. eCollection 2023 Jul 21.
4
Exosome-Based Vaccines: History, Current State, and Clinical Trials.基于外泌体的疫苗：历史、现状和临床试验。
Front Immunol. 2021 Jul 14;12:711565. doi: 10.3389/fimmu.2021.711565. eCollection 2021.
5
The Clinical Trial Landscape for Melanoma Therapies.黑色素瘤疗法的临床试验概况
J Clin Med. 2019 Mar 15;8(3):368. doi: 10.3390/jcm8030368.
6
Melanoma: tumor microenvironment and new treatments.黑色素瘤：肿瘤微环境与新疗法
An Bras Dermatol. 2017 Mar-Apr;92(2):156-166. doi: 10.1590/abd1806-4841.20176183.
7
MAGE-A Antigens and Cancer Immunotherapy.黑色素瘤相关抗原A（MAGE-A）与癌症免疫治疗
Front Med (Lausanne). 2017 Mar 8;4:18. doi: 10.3389/fmed.2017.00018. eCollection 2017.
8
Peptide-based vaccines for cancer therapy.用于癌症治疗的肽基疫苗。
Hum Vaccin Immunother. 2014;10(11):3175-8. doi: 10.4161/hv.29418.
9
Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.通过疫苗疗法诱导人类和犬类脑肿瘤产生治疗反应的成败：最新技术综述
Crit Rev Immunol. 2014;34(5):399-432. doi: 10.1615/critrevimmunol.2014011577.
10
Guidance for peptide vaccines for the treatment of cancer.用于癌症治疗的肽疫苗治疗指南。
Cancer Sci. 2014 Jul;105(7):924-31. doi: 10.1111/cas.12443.